GLP1R and Hyperglycemia: To a greater or lesser extent, all GLP-1 receptor agonists affect both the basal and prandial components of hyperglycemia in patients with type 2 diabetes, although the main mechanism by which they reduce postprandial hyperglycemia can differ between drugs and with the same drug administered at different mealtimes during the day.